Search for: "RANBAXY PHARMACEUTICALS, INC."
Results 21 - 40
of 101
Sorted by Relevance
|
Sort by Date
13 Sep 2013, 7:43 am
The largest settlement this year involved Ranbaxy, Inc., based in Princeton New Jersey. [read post]
27 Aug 2017, 10:01 pm
Actavis, Inc. [read post]
27 Aug 2017, 10:01 pm
Actavis, Inc. [read post]
12 Jul 2013, 11:00 am
More Than $34 Million to Resolve False Claims Act Allegations Related to Kyphoplasty, Justice.gov, July 2, 2013 Medtronic Spine, Formerly Kyphon Inc., to Pay U.S. $75 Million to Resolve Allegations of Defrauding Medicare, Justice.gov, May 22, 2008 More Blog Posts:Nursing Home to Pay $2.7M for Medicaid Fraud Claims Brought to Light By Whistleblower, Boston Injury Lawyer Blog, March 23, 2013 Whistleblower Lawsuit Accuses Dialysis Company DaVita Inc. of Overbilling Medicare and… [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
8 Nov 2007, 9:00 pm
Due to popular demand, I will have a separate section for Pharmaceutical Industry items from this week. [read post]
21 Sep 2013, 6:55 pm
The Medicare fraud lawsuit is accusing LabCorp. of billing Medicaid fees way over what Premier Inc. purchasing collective members were charged. [read post]
28 Jul 2010, 12:06 am
Ranbaxy Laboratories Inc. [read post]
22 May 2015, 10:38 am
Unusually, a trial took place limited to the issue of infringement and in July 2011, Kitchin J (as he then was) held that Ranbaxy's product did not infringe. [read post]
1 Sep 2010, 6:49 am
Apotex, Inc. [read post]
13 Apr 2011, 5:13 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2-10-cv-00836 (E.D. [read post]
3 Jun 2013, 8:38 am
Next up: another pharmaceutical company, Ranbaxy Laboratories, Ltd. [read post]
10 Oct 2013, 8:42 am
Ranbaxy USA Inc. ($500 Million) Ranbaxy USA Inc., a subsidiary of Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited, agreed to pay a total of $500 million to settle criminal and civil allegations filed against the company. [read post]
3 Jun 2015, 9:55 am
Actavis, Inc., 133 S. [read post]
27 Jun 2012, 5:38 am
That day has come with Sandoz Inc. [read post]
18 Aug 2010, 12:19 am
King Pharmaceuticals, Inc. v. [read post]
9 Dec 2009, 3:59 pm
Teva Pharmaceuticals USA Inc. [read post]
24 Feb 2014, 10:38 pm
Omnicare, Inc., a qui tam case brought in Maryland by a former employee of the long-term care pharmacy company, Omnicare. [read post]
20 Mar 2014, 3:49 pm
Jurors in a state court have awarded Kamie Kendall Rees $1,587,928 in her Accutane injury lawsuit against drug maker Hoffman La Roche Inc. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
